BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ingen Technologies, Inc. (IGTN) Announces Results Of Shareholder Conference To Move To The OTCQB Or AMEX


12/31/2013 9:06:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RIVERSIDE, CA--(Marketwired - December 30, 2013) - Ingen Technologies Inc. (PINKSHEETS: IGNT) (http://ingen-tech.com), the holding company of two subsidiaries; a medical device manufacturing company selling its patented medical products worldwide, and a newly acquired growing wireless telecom business providing services to major telecom companies worldwide, announced the results of the shareholder conference held on December 16th, 2013.

The major highlight of the shareholder teleconference was the approval to accept the option of taking the company to the OTCQB. Gary Tilden, Chairman, and David Hanson, Director conducted the shareholder meeting.

More recently, the company is also strongly considering a listing on the American Stock Exchange (AMEX) pursuant to discussions and the evaluation of a Memorandum of Understanding with Benchmark Advisory Partners.

"This teleconference was an opportunity to reach out to our shareholders and investors to discuss specific changes that, over time, will create better liquidity and exposure of Ingen. The company has resolved the majority of its debt issues, as well as being in the process of removing the DTCC 'CHILL' on its stock," stated Gary Tilden, Chairman. Mr. Tilden further stated, "Both of our subsidiaries are in profitable market sectors with growing industry economics, where increased revenues are beginning to become apparent. This growth should result in stronger shareholder value for our current and future shareholders. The move to the OTCQB or AMEX will only enhance the progress already being made."

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.


CONTACT:
Gary Tilden
951-688-7840
www.ingen-tech.com
Email Contact
www.useatmc.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES